ArticleJournal of medicinal chemistry2024

Discovery of CDC42 Inhibitors with a Favorable Pharmacokinetic Profile and Anticancer In Vivo Efficacy.

Nicoletta Brindani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.